CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Other Versions of this Article:
CVI.00246-07v1
14/10/1370    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raut, S. K.
Right arrow Articles by Godse, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raut, S. K.
Right arrow Articles by Godse, S. R.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, October 2007, p. 1370-1371, Vol. 14, No. 10
1071-412X/07/$08.00+0     doi:10.1128/CVI.00246-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Persistence of Antibodies Induced by Measles-Mumps-Rubella Vaccine in Children in India{triangledown}

S. K. Raut,1 P. S. Kulkarni,1* M. A. Phadke,2 S. S. Jadhav,1 S. V. Kapre,1 R. M. Dhere,1 S. P. Dhorje,1 and S. R. Godse1

Serum Institute of India Ltd., Pune,1 Maharashtra University of Health Sciences, Nasik, India2

Received 15 June 2007/ Returned for modification 27 June 2007/ Accepted 6 August 2007

Antibody levels in 41 Indian girls were measured 6 years after measles-mumps-rubella (MMR) vaccination. Rates of seropositivity were 88% (measles antibodies), 95% (mumps antibodies), and 100% (rubella antibodies). The MMR vaccine induces long-term immunity in a majority of vaccinees; however, due to the observation of some seronegative vaccinees, the policy of administering a second dose of the MMR vaccine seems appropriate.

* Corresponding author. Mailing address: Serum Institute of India Ltd., Pune, 212/2, Hadapsar, Pune-411028, India. Phone: 91-20-26602384. Fax: 91-20-26993945. E-mail: drpsk{at}seruminstitute.com

{triangledown} Published ahead of print on 15 August 2007.

Clinical and Vaccine Immunology, October 2007, p. 1370-1371, Vol. 14, No. 10
1071-412X/07/$08.00+0     doi:10.1128/CVI.00246-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.